Evolution of the Average Target: McKesson Corporation

Evolution of the Average Target - McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Evolution of the Target Price - McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

ce77d5.pTUfGdIDBci01nENLjhryTsEzyA6n5pk7AhvCUgb1rU.l2JuLYJkd6GBgTVPVHMSvUx9iGRC0twNi30FcBl67tbkeXZ1uXJj_87mBg~a892269ed974656bb624334a70b448cc
10/11 Analyst recommendations: Applovin, Cognex, Humana, MetLife, RocketLab… Zonebourse
10/11 JPMorgan Adjusts Price Target on McKesson to $1,255 From $1,042 MT
06/11 Deutsche Bank Adjusts McKesson Price Target to $1,120 From $913 MT
06/11 McKesson Continues 'Impressive' Execution, RBC Says MT
06/11 UBS Adjusts Price Target on McKesson to $1,250 From $1,200, Maintains Buy Rating MT
06/11 RBC Raises Price Target on McKesson to $965 From $845, Keeps Sector Perform Rating MT
06/11 Mizuho Adjusts Price Target on McKesson to $1,050 From $1,020 MT
06/11 Leerink Partners Adjusts Price Target on McKesson to $1,200 From $1,070 MT
06/11 Baird Adjusts Price Target on McKesson to $1,225 From $1,017 MT
06/11 Evercore ISI Adjusts Price Target on McKesson to $1,200 From $1,000 MT
06/11 TD Cowen Adjusts Price Target on McKesson to $1,200 From $1,006 MT
06/11 Nasdaq Tumbles as Wall Street Picks Its Winners and Losers Zonebourse
05/11 Analyst recommendations: Block, Cisco System, Fair Isaac, Skyworks, Duolingo… Zonebourse
20/10 Mizuho Adjusts Price Target on McKesson to $1,020 From $905 MT
16/10 UBS Adjusts McKesson Price Target to $1,200 From $1,080, Maintains Buy Rating MT
13/10 Baird Adjusts Price Target on McKesson to $1,017 From $1,015 MT
07/10 Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030 MT
07/10 Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30 MT
15/09 McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says MT
03/09 Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating MT
20/08 McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says MT
19/08 RBC Initiates McKesson at Sector Perform With $845 Price Target MT
18/08 Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating MT
11/08 Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating MT
07/08 Mizuho Adjusts Price Target on McKesson to $905 From $885 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+5.7%
+1.47%
-0.49%
+5.7%
-1.34%
+9.1%
-5.5%
+16.05%
-7.63%
+2.28%
Average +2.54%
Weighted average by Cap. +2.16%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
1,079.79USD
Average target price
1,144.29USD
Spread / Average Target
+5.97%
High Price Target
1,260.00USD
Spread / Highest target
+16.69%
Low Price Target
965.00USD
Spread / Lowest Target
-10.63%

Analyst Consensus Detail

Analyst consensus - McKesson Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - McKesson Corporation
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - McKesson Corporation
  1. Stock Market
  2. Stocks
  3. MCK Stock
  4. Consensus McKesson Corporation